Hybrid carcinomas of the salivary glands: Report of nine cases with a clinicopathologic, immunohistochemical, and p53 gene alteration analysis

Modern Pathology

Volumn 15, Issue 7, 2002, Pages 724-733

  Nagao, Toshitaka ^a   Sugano, Isamu ^b   Ishida, Yasuo ^b   Asoh, Akira ^b   Munakata, Shigeru ^b   Yamazaki, Kazuto ^b   Konno, Akiyoshi ^c   Iwaya, Keiichi ^a   Shimizu, Tohru ^a   Serizawa, Hiromi ^a   Ebihara, Yoshiro ^a  

^a TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^b TEIKYO UNIVERSITY HOSPITAL   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Hybrid carcinoma; Lacrimal gland; p53; Parotid gland; Salivary duct carcinoma; Salivary gland

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ACINAR CELL CARCINOMA; ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER GRADING; CELL COMPOSITION; CERVICAL LYMPH NODE; CLINICAL ARTICLE; EPITHELIUM CELL; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LACRIMAL GLAND; LYMPH NODE METASTASIS; MALE; MALIGNANT TRANSFORMATION; MICROSATELLITE MARKER; MIXED TUMOR; MOLECULAR GENETICS; MYOEPITHELIOMA; MYOEPITHELIUM CELL; PAROTID GLAND CANCER; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; SALIVARY GLAND DUCT; SALIVARY GLAND HYBRID CARCINOMA; SQUAMOUS CELL CARCINOMA; SUBMANDIBULAR GLAND;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; POLYMERASE CHAIN REACTION; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 18444416030     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000018977.18942.FD     Document Type: Article

References (33)

1. Hybrid tumors of salivary glands: Definition and classification of five rare cases
2. Salivary duct carcinoma
3. Combined acinic cell mucoepidermoid carcinoma of the parotid gland: Report of a case with immunohistochemical study
4. A hybrid carcinoma: Adenoid cystic carcinoma and salivary duct carcinoma of the salivary gland: An immunohistochemical study
5. Pitfalls in salivary gland pathology: Hybrid epithelial myoepithelial carcinoma and adenoid cystic carcinoma
6. Hybrid carcinomas of salivary glands: Report of 4 cases and review of the literature
7. Hybrid carcinoma of the salivary gland: Salivary duct adenocarcinoma adenoid cystic carcinoma
8. Hybrid carcinoma of the salivary gland
9. Hybrid carcinomas of salivary glands
10. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology
11. Multiple tumours of the salivary glands: Terminology and nomenclature
12. Synchronous tumors arising in a single major salivary gland
13. Epithelial-myoepithelial carcinoma of the salivary glands, a study of 22 cases
14. Epithelial-myoepithelial carcinoma of salivary glands: A clinicopathologic, DNA flow cytometric, and immunohistochemical study of Ki-67 and HER-2/neu oncogene
15. Salivary duct carcinoma: Clinicopathologic and immunohistochemical review of 26 cases
16. Dedifferentiated acinic cell (acinous) carcinoma of the parotid gland
17. Dedifferentiation in adenoid cystic carcinoma of salivary gland: An uncommon complication associated with an accelerated clinical course
18. High-grade carcinoma component in epithelial-myoepithelial carcinoma of salivary glands clinicopathological, immunohistochemical and flow-cytometric study of three cases
19. Sarcomatoid salivary duct carcinoma of the parotid gland
20. Tumors of the salivary glands
21. Salivary and lacrimal glands
22. Hybrid tumors or salivary gland tumors sharing common differentiation pathways? Reexamining adenoid cystic and epithelial-myoepithelial carcinomas
23. Intercalated duct hyperplasia: Possible relationship to epithelial-myoepithelial carcinoma and hybrid tumours of salivary gland
24. Immunohistochemical analysis of basal cell adenocarcinoma
25. Adenoid cystic carcinoma of the salivary glands: An immunohistochemical analysis
26. Salivary gland malignant myoepithelioma: A clinicopathologic and immunohistochemical study of ten cases
27. p53 oncoprotein expression in parotid gland carcinoma is associated with clinical outcome
28. Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma
29. Coexpression of p53 and c-erbB-2 proteins is associated with histological type, tumour stage, and cell proliferation in malignant salivary gland tumors
30. Basal cell adenocarcinoma of the salivary glands: Comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2
31. DNA analysis at p53 locus in adenoid cystic carcinoma: Comparison of molecular study and p53 immunostaining